1997
Sleep/waking effects of a selective 5-HT1A receptor agonist given systemically as well as perfused in the dorsal raphe nucleus in rats
Bjorvatn B, Fagerland S, Eid T, Ursin R. Sleep/waking effects of a selective 5-HT1A receptor agonist given systemically as well as perfused in the dorsal raphe nucleus in rats. Brain Research 1997, 770: 81-88. PMID: 9372206, DOI: 10.1016/s0006-8993(97)00758-0.Peer-Reviewed Original ResearchConceptsDorsal raphe nucleusSlow-wave sleepRaphe nucleusSleep/Rapid eye movement (REM) sleepREM sleep increaseDeep slow wave sleepEye movement sleepArtificial cerebrospinal fluidMesopontine neuronsAutoreceptor stimulationReceptor agonistMovement sleepREM sleepCerebrospinal fluidWave sleepSleep increasesDPATPerfusionSleepAgonistsFourfold increaseBehavioral syndromeSyndromeNeurotransmission
1995
Differential neuronal vulnerability to amino-oxyacetate and quinolinate in the rat parahippocampal region
Eid T, Du F, Schwarcz R. Differential neuronal vulnerability to amino-oxyacetate and quinolinate in the rat parahippocampal region. Neuroscience 1995, 68: 645-656. PMID: 8577365, DOI: 10.1016/0306-4522(95)00183-j.Peer-Reviewed Original ResearchConceptsAcute behavioral seizuresBehavioral seizuresDizocilpine maleateNeuronal lossEntorhinal cortexEndogenous N-methyl-D-aspartate receptor agonistN-methyl-D-aspartate receptor antagonist dizocilpine maleateLayer IIIN-methyl-D-aspartate receptor agonistParahippocampal regionN-methyl-D-aspartate (NMDA) receptor subtypeDifferential neuronal vulnerabilityDorsal perirhinal cortexPreferential neuronal lossTemporal lobe epilepsyChloral hydrate anesthesiaLower anesthetic doseNeuropathological sequelaeLobe epilepsyNeuropathological changesLayer VNeuronal vulnerabilityPreferential degenerationAnesthetic doseReceptor agonist